ch
Feedback
JAMA (Journal of the American Medical Association)

JAMA (Journal of the American Medical Association)

前往频道在 Telegram

All the latest articles published on JAMA before going in to print Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot

显示更多

📈 Telegram 频道 JAMA (Journal of the American Medical Association) 的分析概览

频道 JAMA (Journal of the American Medical Association) (@jamaupdates) 英语 语言赛道中的 是活跃参与者。目前社区聚集了 16 369 名订阅者,在 医学 类别中位列第 1 462,并在 美国 地区排名第 2 277

📊 受众指标与增长动态

невідомо 创建以来,项目保持高速增长,吸引了 16 369 名订阅者。

根据 15 九月, 2026 的最新数据,频道保持稳定运转。过去 30 天订阅人数变化为 316,过去 24 小时变化为 15,整体触达仍然可观。

  • 认证状态: 未认证
  • 互动率 (ER): 平均受众互动率为 4.36%。内容发布后 24 小时内通常能获得 1.90% 的反应,占订阅者总量。
  • 帖子覆盖: 每篇帖子平均可获得 713 次浏览,首日通常累积 311 次浏览。
  • 互动与反馈: 受众积极参与,单帖平均反应数为 1
  • 主题关注点: 内容集中在 patient, disease, treatment, drug, guideline 等核心主题上。

📝 描述与内容策略

作者将该频道定位为表达主观观点的平台:
All the latest articles published on JAMA before going in to print Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot

凭借高频更新(最新数据采集于 16 九月, 2026),频道始终保持新鲜度与高覆盖。分析显示受众积极互动,使其成为 医学 类别中的关键影响点。

16 369
订阅者
+1524 小时
+767 天
+31630 天
吸引订阅者
九月 '26
九月 '26
+150
在0个频道中
八月 '26
+361
在0个频道中
Get PRO
七月 '26
+440
在0个频道中
Get PRO
六月 '26
+422
在0个频道中
Get PRO
五月 '26
+584
在0个频道中
Get PRO
四月 '26
+437
在0个频道中
Get PRO
三月 '26
+217
在0个频道中
Get PRO
二月 '26
+247
在0个频道中
Get PRO
一月 '26
+321
在0个频道中
Get PRO
十二月 '25
+277
在0个频道中
Get PRO
十一月 '25
+366
在2个频道中
Get PRO
十月 '25
+164
在0个频道中
Get PRO
九月 '25
+12
在0个频道中
Get PRO
八月 '25
+29
在0个频道中
Get PRO
七月 '25
+30
在0个频道中
Get PRO
六月 '25
+17
在0个频道中
Get PRO
五月 '25
+9
在0个频道中
Get PRO
四月 '25
+5
在0个频道中
Get PRO
三月 '25
+17
在0个频道中
Get PRO
二月 '25
+12
在0个频道中
Get PRO
一月 '25
+18
在1个频道中
Get PRO
十二月 '24
+237
在0个频道中
Get PRO
十一月 '24
+1 122
在0个频道中
Get PRO
十月 '24
+1 120
在0个频道中
Get PRO
九月 '24
+1 527
在1个频道中
Get PRO
八月 '24
+1 128
在1个频道中
Get PRO
七月 '24
+1 216
在0个频道中
Get PRO
六月 '24
+781
在1个频道中
Get PRO
五月 '24
+797
在1个频道中
Get PRO
四月 '24
+808
在1个频道中
Get PRO
三月 '24
+821
在2个频道中
Get PRO
二月 '24
+753
在1个频道中
Get PRO
一月 '24
+768
在0个频道中
Get PRO
十二月 '23
+716
在1个频道中
Get PRO
十一月 '23
+96
在1个频道中
Get PRO
十月 '23
+86
在0个频道中
Get PRO
九月 '23
+73
在0个频道中
Get PRO
八月 '23
+90
在0个频道中
Get PRO
七月 '23
+107
在0个频道中
Get PRO
六月 '23
+105
在0个频道中
Get PRO
五月 '23
+169
在0个频道中
Get PRO
四月 '23
+128
在0个频道中
Get PRO
三月 '23
+84
在0个频道中
Get PRO
二月 '23
+75
在0个频道中
Get PRO
一月 '23
+71
在0个频道中
Get PRO
十二月 '22
+74
在0个频道中
Get PRO
十一月 '22
+149
在0个频道中
Get PRO
十月 '22
+90
在0个频道中
Get PRO
九月 '22
+138
在0个频道中
Get PRO
八月 '22
+77
在0个频道中
Get PRO
七月 '22
+50
在0个频道中
Get PRO
六月 '22
+96
在0个频道中
Get PRO
五月 '22
+75
在0个频道中
Get PRO
四月 '22
+80
在0个频道中
Get PRO
三月 '22
+65
在0个频道中
Get PRO
二月 '22
+26
在0个频道中
Get PRO
一月 '22
+56
在0个频道中
Get PRO
十二月 '21
+44
在0个频道中
Get PRO
十一月 '21
+39
在0个频道中
Get PRO
十月 '21
+61
在0个频道中
Get PRO
九月 '21
+66
在0个频道中
Get PRO
八月 '21
+65
在0个频道中
Get PRO
七月 '21
+96
在0个频道中
Get PRO
六月 '21
+120
在0个频道中
Get PRO
五月 '21
+130
在0个频道中
Get PRO
四月 '21
+812
在0个频道中
日期
订阅者增长
提及
频道
16 九月+1
15 九月+15
14 九月+4
13 九月+24
12 九月+9
11 九月+9
10 九月+13
09 九月+4
08 九月+11
07 九月+9
06 九月+16
05 九月+11
04 九月+5
03 九月0
02 九月+15
01 九月+4
频道帖子
Caring Collectively Through Palliative Care Partnerships https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2853900 End-of-life cancer care represents a pivotal period for patients, families, and care providers. Palliative care consultation can enhance the quality of end-of-life care for patients with cancer, which has been demonstrated to be beneficial. The palliative care workforce, while growing, is still inadequate to meet patient care needs. Furthermore, the effectiveness of palliative care programs has been inconsistent in prior research, with some programs improving quality of life but not health care utilization. Specifically, hospice utilization varies widely despite the consistent presence of palliative care services in many oncology settings.

2
Administrative Bloat in Neurology and Academic Medicine https://jamanetwork.com/journals/jamaneurology/fullarticle/2854115 This Viewpoint describes the growth of administrative work across universities, health care, and research and suggests 5 questions a neurology department should ask about any administrative process.
459
3
Clinical Characteristics, Neuroimaging Findings, and Mortality in Korsakoff Syndrome https://jamanetwork.com/journals/jamaneurology/fullarticle/2854116 This cohort study of French adults diagnosed with Korsakoff syndrome identifies clinical features and outcomes of patients in routine clinical practice and examines factors associated with mortality.
419
4
IVIG in Idiopathic Inflammatory Myopathies https://jamanetwork.com/journals/jamaneurology/fullarticle/2854117 This randomized clinical trial evaluates the use of intravenous immune globulin as add-on treatment in newly diagnosed idiopathic inflammatory myopathy.
371
5
CAA-Like Brain Imaging and Dural AVF https://jamanetwork.com/journals/jamaneurology/fullarticle/2854118 This case report describes a patient in their 70s initially diagnosed with cerebral amyloid angiopathy whose diagnosis was challenged with repeat magnetic resonance imaging, which revealed arterialized left temporal cortical vein with an adjacent venous aneurysm.
360
6
Weight Loss in Older Adults With Persistent Atrial Fibrillation https://jamanetwork.com/journals/jama/fullarticle/2854052 To the Editor In the LOSE-AF randomized clinical trial, a low-calorie diet and behavioral support program achieved significant weight loss but did not improve atrial fibrillation (AF) symptoms, AF burden, or subsequent rhythm-control outcomes in older patients with persistent AF. We believe an imbalance in baseline rhythm-control therapies may have affected the interpretation of these null findings.
383
7
Azithromycin for Cesarean Delivery https://jamanetwork.com/journals/jama/fullarticle/2854053 Preventing maternal morbidity and mortality remains an urgent global priority, yet progress has been unsatisfactory. Although maternal mortality has declined globally, the rates have increased in the US and infections are among the top causes of preventable deaths. Among women undergoing cesarean delivery (the most common major surgical procedure in the US), the risk of infection is many times higher than after vaginal delivery, underscoring the importance of effective prophylaxis.
382
8
Idiopathic Normal Pressure Hydrocephalus: A Review https://jamanetwork.com/journals/jama/fullarticle/2854046 This Review discusses the pathophysiology, epidemiology, risk factors, clinical presentation, diagnosis, treatment, and prognosis of idiopathic normal pressure hydrocephalus.
374
9
Error in Results https://jamanetwork.com/journals/jama/fullarticle/2854054 The Original Investigation titled “Gastric Residual Volume Assessment in Critically Ill Children: The GASTRIC-PICU Randomized Clinical Trial,” published on June 12, 2026, was corrected to update the number of participants in the usual care group in Figure 1 and P values for the intention-to-treat clinical co–primary outcome and per-protocol analysis in the Results section to be consistent with Table 2. This article was corrected online.
373
10
World Trade Center Exposure at 25 Years https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2853739 This Viewpoint discusses how clinicians can screen patients for exposure to the World Trade Center attacks on September 11, 2001.
657
11
Study Finds Artery Damage in Young Adults With CKM Syndrome https://jamanetwork.com/journals/jama/fullarticle/2854233 Cardiovascular-kidney-metabolic (CKM) syndrome is prevalent among young adults and is associated with greater signs of early artery damage, according to a study published in Circulation: Population Health and Outcomes. Nearly 80% of participants had CKM syndrome stages 1 to 3, which were linked to worse cardiovascular health.
676
12
Nicotine Vapes May Aid in Smoking Cessation https://jamanetwork.com/journals/jama/fullarticle/2854234 More people may quit smoking when using nicotine e-cigarettes, also known as vapes, compared with conventional nicotine replacement therapies (NRT) such as gum or patches and quitting with or without behavioral support, according to an updated Cochrane review.
617
13
Audio Highlights September 11, 2026 https://jamanetwork.com/journals/jama/fullarticle/2854237 Listen to the JAMA Editor’s Summary for an overview and discussion of the important articles appearing in JAMA.
571
14
Psilocybin https://jamanetwork.com/journals/jama/fullarticle/2853938 This JAMA Insights discusses the medical use of psilocybin, particularly for depression treatment, including emerging potential indications, safety, and future use.
726
15
Medicine’s Role in Mental Health Promotion https://jamanetwork.com/journals/jama/fullarticle/2853937 Dana L. Farnsworth, M.D., Cambridge, Mass.
664
16
Loberamisal for Acute Ischemic Stroke Research Summary https://jamanetwork.com/journals/jama/fullarticle/2854041 This trial evaluated whether intravenous loberamisal improves functional outcomes and is safe in adults with acute ischemic stroke treated within 48 hours of symptom onset.
627
17
Patient Information: Psilocybin https://jamanetwork.com/journals/jama/fullarticle/2854042 This JAMA Patient Page describes the psychedelic compound psilocybin, its medical and recreational use, and its potential side effects.
561
18
Loberamisal for Acute Ischemic Stroke https://jamanetwork.com/journals/jama/fullarticle/2854043 This randomized clinical trial evaluates whether intravenous loberamisal improves functional outcomes and maintains an acceptable safety profile in patients with acute ischemic stroke treated within 48 hours of symptom onset.
520
19
Neuroprotective Therapy for Acute Ischemic Stroke https://jamanetwork.com/journals/jama/fullarticle/2854044 A remarkable era in acute ischemic stroke care is now coming to a close—the period of the “reperfusion revolution.” Over the past few decades, pharmacological and mechanical flow restoration therapies became steadily more effective. By restoring blood flow and terminating the ischemic period, reperfusion salvages those cerebral tissues not yet irreversibly injured. However, the reperfusion strategy in acute stroke care is now reaching its limits. Current endovascular thrombectomy approaches reopen over 85% of occluded arteries, leaving little scope for further advance. And successful reperfusion treatment alone clearly only partially solves the therapeutic challenge. Among patients with ischemic stroke due to large-vessel occlusion who receive endovascular thrombectomy, more than two-thirds nevertheless have a disabled final outcome. Restoring blood flow yields incomplete recoveries because some irreversible injury accrues before recanalization can be achieved and additional injury is generated by reperfusion itself. To fully eradicate stroke-related disability, complementary therapies are needed, including: bridging neuroprotection agents, which allow brain cells to tolerate ischemia until reperfusion is attained; reperfusion neuroprotection agents, which avert reperfusion injury; and neuroreparative agents, which promote postinjury reorganization of neurons and synapses.
536
20
Rheumatoid Arthritis in Adults: A Review https://jamanetwork.com/journals/jama/fullarticle/2853931 This Review discusses the pathogenesis, epidemiology, risk factors, clinical presentation, diagnosis, treatment, and prognosis of rheumatoid arthritis (RA).
451